Cargando…

Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates

BACKGROUND: Anti-tumor necrosis factor (anti-TNF) agents are an effective, but costly, treatment for spondyloarthritis (SpA). Worldwide, multiple sets of access criteria aim to restrict anti-TNF therapy to patients with specific clinical characteristics, yet the influence of access criteria on anti-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harvard, Stephanie, Guh, Daphne, Bansback, Nick, Richette, Pascal, Saraux, Alain, Fautrel, Bruno, Anis, Aslam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590198/ https://www.ncbi.nlm.nih.gov/pubmed/28904528 http://dx.doi.org/10.1186/s12962-017-0081-8

Ejemplares similares

Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohort
por: Harvard, Stephanie, et al.
Publicado: (2016)

The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis
por: Guh, Daphne P, et al.
Publicado: (2009)

Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years
por: Lucasson, Florian, et al.
Publicado: (2022)

How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort
por: Nikiphorou, Elena, et al.
Publicado: (2021)

Evolution of Direct Costs in the First Years of Rheumatoid Arthritis: Impact of Early versus Late Biologic Initiation - An Economic Analysis Based on the ESPOIR Cohort
por: Chevreul, Karine, et al.
Publicado: (2014)

Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohort
por: Nikiphorou, Elena, et al.
Publicado: (2021)

Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies
por: Bansback, Nick, et al.
Publicado: (2012)

Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study
por: Zhang, Wei, et al.
Publicado: (2015)

Hip Pain Associated with Acetabular Dysplasia in Patients with Suspected Axial Spondyloarthritis: DESIR Cohort Data
por: Guellec, Dewi, et al.
Publicado: (2022)

When does the use of individual patient data in network meta-analysis make a difference? A simulation study
por: Kanters, Steve, et al.
Publicado: (2021)

The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist
por: Burgos-Vargas, Ruben
Publicado: (2012)

Ontario’s plunging price-caps on generics: deeper dives may drown some drugs
por: Anis, Aslam, et al.
Publicado: (2011)

Fears and Beliefs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Study
por: Berenbaum, Francis, et al.
Publicado: (2014)

Takayasu’s arteritis occurring under TNF blockers in a patient with spondyloarthritis: is it an association or a paradoxical effect?
por: Rezgui, Amel, et al.
Publicado: (2021)

Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
por: Dougados, Maxime, et al.
Publicado: (2023)

Validity of the work productivity and activity impairment questionnaire - general health version in patients with rheumatoid arthritis
por: Zhang, Wei, et al.
Publicado: (2010)

Impact of etanercept tapering on work productivity in patients with early rheumatoid arthritis: results from the PRIZE study
por: Zhang, Wei, et al.
Publicado: (2016)

Synovial Tissue Response to Treatment with TNF Blockers in Peripheral Spondyloarthritis
por: Paramarta, Jacqueline E, et al.
Publicado: (2011)

Relative overexpression of membrane-bound versus soluble TNF in spondyloarthritis
por: Ambarus, Carmen A, et al.
Publicado: (2012)

Cardiovascular risk in patients with spondyloarthritis and association with anti-TNF drugs
por: Chan, Shirley Chiu Wai, et al.
Publicado: (2021)

The Impact of Fibromyalgia in Spondyloarthritis: From Classification Criteria to Outcome Measures
por: Alunno, Alessia, et al.
Publicado: (2018)

Classification vs diagnostic criteria: the challenge of diagnosing axial spondyloarthritis
por: Poddubnyy, Denis
Publicado: (2020)

Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART
por: Kanters, Steve, et al.
Publicado: (2021)

Reporting of patient-perceived impact of rheumatoid arthritis and axial spondyloarthritis over 10 years: a systematic literature review
por: Gossec, Laure, et al.
Publicado: (2014)

Making smart investment decisions in clinical research
por: Bansback, Nick, et al.
Publicado: (2015)

Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy
por: Sebastian, Agata, et al.
Publicado: (2017)

Transmembrane TNF drives osteoproliferative joint inflammation reminiscent of human spondyloarthritis
por: Kaaij, Merlijn H., et al.
Publicado: (2020)

Intestinal microbiota changes induced by TNF-inhibitors in IBD-related spondyloarthritis
por: Ditto, Maria Chiara, et al.
Publicado: (2021)

Comorbidity and response to TNF inhibitors in axial spondyloarthritis: longitudinal analysis of the BSRBR-AS
por: Zhao, Sizheng Steven, et al.
Publicado: (2020)

Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort
por: Fautrel, Bruno, et al.
Publicado: (2012)

Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data
por: Granger, Benjamin, et al.
Publicado: (2016)

The Impact of Tiered-Pricing Framework on Generic Entry in Canada
por: Zhang, Wei, et al.
Publicado: (2020)

Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France
por: Dougados, Maxime, et al.
Publicado: (2022)

Patients’ Experiences and Priorities for Accessing Gastroenterology Care
por: Telford, Jennifer J, et al.
Publicado: (2019)

Efficacy of Anti-TNF Agents as Adjunctive Therapy for Knee Synovitis Refractory to Disease-Modifying Antirheumatic Drugs in Patients with Peripheral Spondyloarthritis
por: Sakellariou, Grigorios T., et al.
Publicado: (2013)

Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis
por: Gossec, Laure, et al.
Publicado: (2018)

Evaluation of the performances of ‘typical’ imaging abnormalities of axial spondyloarthritis: results of the cross-sectional ILOS-DESIR study
por: Molto, Anna, et al.
Publicado: (2019)

Onset of lupus like syndrome in patients with spondyloarthritis treated with anti-TNF-α
por: Puertas-Abreu, Eduardo, et al.
Publicado: (2012)

Correction to: Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis
por: Gossec, Laure, et al.
Publicado: (2018)

The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study
por: Bakker, Pauline, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n23i8oklnr7m5qn9rarvgpqfa7